Video adapted from "Biological Warfare & Terrorism: The Military and Public Health Response", Centers for Disease Control and Prevention. Retrieved October 21, 2007.
Francis E. (1921). Tularemia. I. The occurrence of tularemia in nature as a disease of man. Public Health Reports 36(30):1731–53. PMID19314784.
Chakraborty S, Monfett M, Maier TM, Benach JL, Frank DW, Thanassi DG. (2008). Type IV pili in Francisella tularensis: roles of pilF and pilT in fiber assembly, host cell adherence, and virulence. Infection and Immunity. 76(7):2852-61. PMID18426883.
Santic, Marina et al. (2005). The Francisella tularensis pathogenicity island protein IgIC and its regulator MgIA are essential for modulating phagosome biogenesis and subsequent bacterial escape into the cytoplasm. Cell Microbiology. 7(7):969-79. PMID15953029.
Lai XH, Wang SY, Edebro H, Sjöstedt A. (2003). Francisella strains express hemolysins of distinct characteristics. FEMS Microbiology Letters. 15;224(1):91-5. PMID12855173.
Lindemann SR, Peng K, Long ME, Hunt JR, Apicella MA, Monack DM, Allen LA, Jones BD. (2011). Francisella tularensis Schu S4 O-antigen and capsule biosynthesis gene mutants induce early cell death in human macrophages. Infection and Immunity. 79(2):581-94. PMID21078861
Sjöstedt A. (2007). Tularemia: history, epidemiology, pathogen physiology, and clinical manifestations. Annals of the New York Academy of Sciences. 1105:1-29. PMID17395726
Mörner T. (December 1992). The ecology of tularaemia. Revue scientifique et technique. 11(4):1123–30. PMID1305858.
Plourde PJ, Embree J, Friesen F, Lindsay G, Williams T. (June 1992). Glandular tularemia with typhoidal features in a Manitoba child. Canadian Medical Association Journal. 146(11):1953–5. PMID1596844.
Enderlin G, Morales L, Jacobs RF, Cross JT. (July 1994). Streptomycin and alternative agents for the treatment of tularemia: review of the literature. Clinical Infectious Diseases. 19(1):42–7. PMID7948556.
Ellis J, Oyston P, Green M, Titball R. (2002). Tularemia. Clinical Microbiology Reviews. 15(4):631–46. PMID12364373.
Reintjes R, Dedushaj I, Gjini A, Jorgensen TR, Cotter B, Lieftucht A, et al. (2002). Tularemia Outbreak Investigation in Kosovo: Case Control and Environmental Studies. Emerging Infectious Diseases journal. 8(1):69-73. PMID11749751.
Dennis DT, Inglesby TV, Henderson DA, et al. (June 2001). Tularemia as a biological weapon: medical and public health management. JAMA. 285(21):2763–73. PMID11386933.
Kadull PJ, Reames HR, Coriell LL, Foshay L. (1950). Studies on tularemia. V. Immunization of man. Journal of Immunology. 65(4):425-35. PMID14794905.
Overholt EL, Tigertt WD, Kadull PJ et al. (1961). An analysis of forty-two cases of laboratory-acquired tularemia. Treatment with broad spectrum antibiotics. American Journal of Medicine. 30:785-806. PMID13731776.
Saslaw S. et al. (1961). Tularemia vaccine study. I. Intracutaneous challenge. Archives of Internal Medicine. 107:689-701. PMID13746668.
Evans ME, Gregory DW, Schaffner W, McGee ZA. (1985). Tularemia: a 30-year experience with 88 cases. Medicine (Baltimore) 64(4):251-69. PMID3892222.
Sato T, Fujita H, Ohara Y, Homma M. (1990). Microagglutination test for early and specific serodiagnosis of tularemia. Journal of Clinical Microbiology. 28(10):2372-4. PMID2229367.
Kiliç S, Celebi B, Yeşilyurt M. (2012). Evaluation of a commercial immunochromatographic assay for the serologic diagnosis of tularemia. Diagnostic Microbiology and Infectious Disease. 74(1):1-5. PMID22770772.
Seibold E, Maier T, Kostrzewa M, Zeman E, Splettstoesser W. (2009). A sensitive liquid chromatography/mass spectrometry-based assay for quantitation of amino-containing moieties in lipid A. Rapid Communications in Mass Spectrometry. 23(3):433-42. PMID19130491.
Croddy E, Krcalova S. (October 2001). Tularemia, Biological Warfare, and the Battle for Stalingrad (1942-1943). Military Medicine. 166(10):837-8. PMID11603230.
